Wang et al. found that the proliferative and invasive abilities of cervical cancer could be enhanced by downregulation of miR-214, which was completed by modulating the PI3K/AKT/mTOR signalling pathway or targeting ARL2, EZH2, and FOXM1 [20–23]. This evidence concerns the gene EZH2 and cervical cancer.